• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球胰腺癌患病率趋势预测至 2040 年:基于疾病死亡建模研究。

Global Trend in Pancreatic Cancer Prevalence Rates Through 2040: An Illness-Death Modeling Study.

机构信息

Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Cancer Med. 2024 Oct;13(20):e70318. doi: 10.1002/cam4.70318.

DOI:10.1002/cam4.70318
PMID:39440551
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11497012/
Abstract

BACKGROUND

Despite remarkable progress in contemporary medical technology and enhanced survival outcomes for various cancer types, pancreatic cancer (PC) continues to stand out as a particularly deadly gastrointestinal malignancy. Given a persistent rise in both incidence and the corresponding mortality rates of PC globally, evaluations of PC burden by sex are of great importance. Here, we used the illness-death multi-state model (IDM) to forecast the prevalence of PC through the year 2040.

METHODS

IDM was established based on obtainable data to predict the future prevalence of PC on global, regional, and national scales from 2019 to 2040. Analyses were also performed regarding sex and 95% confidence intervals (CIs) are presented for all estimates.

RESULTS

The projected prevalence rate for 2040 is anticipated to be 6.093 ([95% CI 5.47-6.786] per 100,000) worldwide, indicating a significant increase of 31.45% since 1990, and a 12.29% increase since 2019. The estimated average annual increase since 2020 was 0.5%. Considering sex differences, females are expected to have a steeper slope in prevalence rate than males. Intriguingly, when considering the percentage changes between the periods of 2019-2040 and 1990-2019 for both sexes, females exhibited 29% and 11% increase relative to males (2.6-fold greater increase).

CONCLUSIONS

By 2040, it is predicted that the prevalence of PC will increase globally, with women being at higher risk of developing the disease. Considering the percentage changes, regions with lower socioeconomic status are anticipated to face a greater risk of experiencing PC compared to other geographical areas.

摘要

背景

尽管当代医学技术取得了显著进步,各种癌症类型的生存率也有所提高,但胰腺癌(PC)仍然是一种极具致命性的胃肠道恶性肿瘤。由于全球范围内 PC 的发病率和死亡率持续上升,因此按性别评估 PC 的负担至关重要。在这里,我们使用疾病-死亡多状态模型(IDM)来预测 2040 年 PC 的患病率。

方法

基于可获得的数据建立 IDM,以预测 2019 年至 2040 年全球、区域和国家范围内 PC 的未来患病率。还针对性别进行了分析,所有估计值均提供了 95%置信区间(CI)。

结果

预计 2040 年的预计患病率为 6.093([95%CI 5.47-6.786]/100,000),与 1990 年相比增长了 31.45%,与 2019 年相比增长了 12.29%。自 2020 年以来,估计的年平均增长率为 0.5%。考虑到性别差异,女性的患病率增长率预计高于男性。有趣的是,当考虑 2019-2040 年和 1990-2019 年两个时期的性别之间的百分比变化时,女性的增长幅度比男性高 29%(增加了 2.6 倍)。

结论

到 2040 年,预计全球 PC 的患病率将会增加,女性患该病的风险更高。考虑到百分比变化,与其他地理区域相比,社会经济地位较低的地区预计将面临更大的 PC 发病风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3d/11497012/ee110383fa8c/CAM4-13-e70318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3d/11497012/7416f710cb4b/CAM4-13-e70318-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3d/11497012/9398d2abd436/CAM4-13-e70318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3d/11497012/ee110383fa8c/CAM4-13-e70318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3d/11497012/7416f710cb4b/CAM4-13-e70318-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3d/11497012/9398d2abd436/CAM4-13-e70318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3d/11497012/ee110383fa8c/CAM4-13-e70318-g002.jpg

相似文献

1
Global Trend in Pancreatic Cancer Prevalence Rates Through 2040: An Illness-Death Modeling Study.全球胰腺癌患病率趋势预测至 2040 年:基于疾病死亡建模研究。
Cancer Med. 2024 Oct;13(20):e70318. doi: 10.1002/cam4.70318.
2
Age-period-cohort analysis of global, regional, and national pancreatic cancer incidence, mortality, and disability-adjusted life years, 1990-2019.1990-2019 年全球、地区和国家胰腺癌发病率、死亡率和伤残调整生命年的年龄-时期-队列分析。
BMC Cancer. 2024 Aug 28;24(1):1063. doi: 10.1186/s12885-024-12835-0.
3
Changing Trends in the Global Disease Burden of Pancreatic Cancer from 1990 to 2030.1990年至2030年全球胰腺癌疾病负担的变化趋势
Dig Dis Sci. 2024 Jul;69(7):2450-2461. doi: 10.1007/s10620-024-08465-y. Epub 2024 May 9.
4
Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013.中风发病率、患病率、死亡率及伤残调整生命年的性别差异:全球疾病负担研究2013结果
Neuroepidemiology. 2015;45(3):203-14. doi: 10.1159/000441103. Epub 2015 Oct 28.
5
Pancreatic cancer mortality trends attributable to high fasting blood sugar over the period 1990-2019 and projections up to 2040.1990 年至 2019 年期间高空腹血糖导致的胰腺癌死亡率趋势及 2040 年预测。
Front Endocrinol (Lausanne). 2024 Jul 5;15:1302436. doi: 10.3389/fendo.2024.1302436. eCollection 2024.
6
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家 5 岁以下儿童死亡率、成人死亡率、特定年龄死亡率和预期寿命,1970-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1084-1150. doi: 10.1016/S0140-6736(17)31833-0.
7
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Temporal trends of thyroid cancer in China and globally from 1990 to 2021: an analysis of the global burden of Disease Study 2021.中国和全球甲状腺癌的时间趋势:2021 年全球疾病负担研究分析。
Sci Rep. 2024 Oct 26;14(1):25538. doi: 10.1038/s41598-024-77663-5.
10
Global, regional and national burden of pancreatic cancer, 1990 to 2017: Results from the Global Burden of Disease Study 2017.全球、地区和国家胰腺癌负担,1990 年至 2017 年:来自 2017 年全球疾病负担研究的结果。
Pancreatology. 2020 Apr;20(3):462-469. doi: 10.1016/j.pan.2020.02.011. Epub 2020 Feb 21.

引用本文的文献

1
Brightly Visualizing Pancreatic Cancer Margins in Orthotopic Mouse Models with an Anti-CA19-9 Antibody Conjugated to a Near-Infrared Fluorophore.使用与近红外荧光团偶联的抗CA19-9抗体在原位小鼠模型中清晰可视化胰腺癌边缘
Cancers (Basel). 2025 Aug 10;17(16):2617. doi: 10.3390/cancers17162617.
2
Cabo Verde's cancer crisis: the fastest-rising mortality burden in the world.佛得角的癌症危机:全球上升速度最快的死亡负担。
Med Oncol. 2025 Aug 23;42(10):440. doi: 10.1007/s12032-025-02995-9.
3
Harnessing artificial intelligence for detection of pancreatic cancer: a machine learning approach.

本文引用的文献

1
Illness-Death Model as a Framework for Chronic Disease Burden Projection: Application to Mental Health Epidemiology.疾病-死亡模型作为慢性病负担预测的框架:在心理健康流行病学中的应用
Front Epidemiol. 2022 Jun 27;2:903652. doi: 10.3389/fepid.2022.903652. eCollection 2022.
2
Increasing Pancreatic Cancer Incidence in Young Women in the United States: A Population-Based Time-Trend Analysis, 2001-2018.美国年轻女性中胰腺癌发病率的增加:基于人群的时间趋势分析,2001-2018 年。
Gastroenterology. 2023 May;164(6):978-989.e6. doi: 10.1053/j.gastro.2023.01.022. Epub 2023 Feb 10.
3
Model-based screening for pancreatic cancer in Sweden.
利用人工智能检测胰腺癌:一种机器学习方法。
Clin Exp Med. 2025 Jul 1;25(1):228. doi: 10.1007/s10238-025-01761-5.
4
Microbiota as a state-of-the-art approach in precision medicine for pancreatic cancer management: A comprehensive systematic review.微生物群作为胰腺癌精准治疗的一种前沿方法:一项全面的系统评价。
iScience. 2025 Mar 28;28(5):112314. doi: 10.1016/j.isci.2025.112314. eCollection 2025 May 16.
5
Polyallylamine Hydrochloride-Modified Bovine Serum Albumin Nanoparticles Loaded with α-Solanine for Chemotherapy of Pancreatic Cancer.负载α-茄碱的聚烯丙基氯化铵修饰牛血清白蛋白纳米粒用于胰腺癌化疗
Int J Nanomedicine. 2025 Apr 7;20:4235-4255. doi: 10.2147/IJN.S508936. eCollection 2025.
6
The Erosion of Healthcare and Scientific Integrity: A Growing Concern.医疗保健与科学诚信的侵蚀:日益令人担忧的问题。
J Healthc Leadersh. 2025 Feb 21;17:23-43. doi: 10.2147/JHL.S506767. eCollection 2025.
基于模型的瑞典胰腺癌筛查。
Scand J Gastroenterol. 2023 May;58(5):534-541. doi: 10.1080/00365521.2022.2142481. Epub 2022 Nov 28.
4
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
5
Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039.2019 年欧洲胰腺癌负担及归因风险因素,以及 2039 年预测。
Int J Cancer. 2021 Sep 1;149(5):993-1001. doi: 10.1002/ijc.33617. Epub 2021 May 18.
6
Projected economic burden of pancreatic cancer in Sweden in 2030.2030 年瑞典胰腺癌预估经济负担。
Acta Oncol. 2021 Jul;60(7):866-871. doi: 10.1080/0284186X.2021.1892821. Epub 2021 Mar 17.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Prediction of survival and recurrence in patients with pancreatic cancer by integrating multi-omics data.通过整合多组学数据预测胰腺癌患者的生存和复发情况。
Sci Rep. 2020 Nov 3;10(1):18951. doi: 10.1038/s41598-020-76025-1.
9
Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study.2017 年至 2100 年 195 个国家和地区的生育率、死亡率、迁移和人口预测情景:全球疾病负担研究的预测分析。
Lancet. 2020 Oct 17;396(10258):1285-1306. doi: 10.1016/S0140-6736(20)30677-2. Epub 2020 Jul 14.
10
The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家和地区 1990-2017 年胰腺癌的全球、区域和国家负担及其可归因危险因素:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2019 Dec;4(12):934-947. doi: 10.1016/S2468-1253(19)30347-4. Epub 2019 Oct 21.